Literature DB >> 25771522

[Epidemiology, prevention and risk morbidity factors for lung cancer].

Aneta Radziszewska1, Bożenna Karczmarek-Borowska2, Monika Grądalska-Lampart1, Agata A Filip3.   

Abstract

Lung cancer incidence kept increasing dynamically in male population until the late 90s and then there was a sudden drop in the cases and this tendency has been maintained up till now. What seems upsetting, however, is the fact that for female population there is a constant growth in the lung cancer morbidity. Needless to say, Poland still belongs to the countries with high lung cancer incidence and lung cancer mortality. In 2011 the standardized morbidity rate in Poland accounted for 50,0/100 000 in male population and 17,3/100 000 in female population. In Podkarpacie Voivodeship it was 43,6/100 000 for males and 11,8/100 000 for females respectively. Lung cancer incidence and lung cancer mortality seem to increase together with age, and for people 65 and more this type of cancer accounts for approximately 50% of all cancer cases and cancer caused deaths. In spite of various research conducted and great medical progress little can be done to cure lung cancer. The percentage of 5-year survivals increased for males from 10,8% in years 2000-2002 to 11,9% in years 2003-2005, and for females from 15,7% to 16,9%. The main cause of lung cancer is certainly active and passive smoking. It is highly possible that environmental factors are also responsible for lung cancer cases. Among the most devastating are such factors as asbestos, arsenic, aromatic hydrocarbons, individual lifestyle and nutrition, genetic predisposition and finally the pollution, particularly of the air.
© 2015 MEDPRESS.

Entities:  

Keywords:  lung cancer; morbidity and mortality; risk factors

Mesh:

Substances:

Year:  2015        PMID: 25771522

Source DB:  PubMed          Journal:  Pol Merkur Lekarski        ISSN: 1426-9686


  7 in total

1.  Determination of Endothelial Nitric Oxide Synthase Gene Polymorphism and Plasma Asymmetric Dimethyl Arginine Concentrations in Patients with Lung Cancer.

Authors:  Zafer Bayraktutan; Ahmet Kiziltunc; Ebubekir Bakan; Hamit Hakan Alp
Journal:  Eurasian J Med       Date:  2020-06-05

Review 2.  Actin-Binding Proteins as Potential Biomarkers for Chronic Inflammation-Induced Cancer Diagnosis and Therapy.

Authors:  Yu-Gui Zhang; Jiang-Tao Niu; Hong-Wei Wu; Xin-Lei Si; Shu-Juan Zhang; Dong-Hui Li; Tian-Tian Bian; Yue-Feng Li; Xing-Ke Yan
Journal:  Anal Cell Pathol (Amst)       Date:  2021-06-05       Impact factor: 2.916

3.  RTEL1 polymorphisms are associated with lung cancer risk in the Chinese Han population.

Authors:  Shouchun Yan; Ridong Xia; Tianbo Jin; Hui Ren; Hua Yang; Jing Li; Mengdan Yan; Yuanyuan Zhu; Mingwei Chen
Journal:  Oncotarget       Date:  2016-10-25

4.  Deoxypodophyllotoxin Inhibits Non-Small Cell Lung Cancer Cell Growth by Reducing HIF-1α-Mediated Glycolysis.

Authors:  Yuping Yang; Lingling Liu; Jinghui Sun; Shu Wang; Zhongyuan Yang; Honghui Li; Na Huang; Wei Zhao
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

Review 5.  [Changing Epidemic of Lung Cancer & Tobacco and Situation of Tobacco Control 
in China].

Authors:  Xiaonong Zou; Manman Jia; Xin Wang; Xiuyi Zhi
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-08-20

6.  Cancer-associated changes of emotional brain network in non-nervous system metastatic non-small cell lung cancer patients: a structural connectomic diffusion tensor imaging study.

Authors:  Siwen Liu; Xiaoyou Li; Rong Ma; Haixia Cao; Changwen Jing; Zhuo Wang; Dan Chen; Junying Zhang; Yuan Zhang; Jifeng Feng; Jianzhong Wu
Journal:  Transl Lung Cancer Res       Date:  2020-08

7.  CA-125, CA-153, and CYFRA21-1 as clinical indicators in male lung cancer with ocular metastasis.

Authors:  Biao Li; Qing Yuan; Yu-Ting Zou; Ting Su; Qi Lin; Yu-Qing Zhang; Wen-Qing Shi; Rong-Bin Liang; Qian-Min Ge; Qiu-Yu Li; Yi Shao
Journal:  J Cancer       Date:  2020-02-20       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.